Influence of gastrectomy for stomach cancer on type 2 diabetes mellitus for patients with a body mass index less than 30 kg/m 2

Journal of the Korean Surgical Society

Volumn 82, Issue 6, 2012, Pages 347-355

  Kang, Kyu Chul ^a   Shin, Seok Hwan ^a   Lee, Yeon Ji ^a   Heo, Yoon Seok ^a  

^a Inha University Hospital   (South Korea)

Author keywords

Body mass index; Gastrectomy; Gastric bypass; Low BMI; Type 2 diabetes mellitus

Indexed keywords

EID: 84863672122     PISSN: 12260053     EISSN: 20930488     Source Type: Journal    
DOI: 10.4174/jkss.2012.82.6.347     Document Type: Review

References (29)

1. World Health Organization. Facts sheet on diabetes, obesity and overweight. Geneva: World Health Organization; 2006.
2. Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003;237:751-6.
3. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238:467-84.
4. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724-37. (Pubitemid 39346675)
5. Korner J, Bessler M, Cirilo LJ, Conwell IM, Daud A, Restuccia NL, et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 2005;90:359-65. (Pubitemid 40116682)
6. Morínigo R, Moize V, Musri M, Lacy AM, Navarro S, Marin JL, et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2006;91:1735-40.
7. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002;346:1623-30. (Pubitemid 34755670)
8. Friedman MN, Sancetta AJ, Magovern GJ. The amelioration of diabetes mellitus following subtotal gastrectomy. Surg Gynecol Obstet 1955;100:201-4.
9. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004;239: 1-11. (Pubitemid 38176365)
10. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26 Suppl 1:S5-20.
11. Nathan DM. Clinical practice. Initial management of glyce-mia in type 2 diabetes mellitus. N Engl J Med 2002;347: 1342-9. (Pubitemid 35215326)
12. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-44.
13. Frezza EE. Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success? Obes Surg 2004;14:999-1005. (Pubitemid 39093477)
14. Marceau P, Hould FS, Simard S, Lebel S, Bourque RA, Potvin M, et al. Biliopancreatic diversion with duodenal switch. World J Surg 1998;22:947-54. (Pubitemid 28374612)
15. Scopinaro N, Adami GF, Marinari GM, Gianetta E, Traverso E, Friedman D, et al. Biliopancreatic diversion. World J Surg 1998;22:936-46. (Pubitemid 28374611)
16. White S, Brooks E, Jurikova L, Stubbs RS. Long-term outcomes after gastric bypass. Obes Surg 2005;15:155-63. (Pubitemid 40315997)
17. Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 2010;61: 393-411.
18. Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG, Aylwin SJ. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg 2006;93:210-5. (Pubitemid 43259607)
19. Lee H, Kim M, Kwon H, Song K, Kim E. The impact of metabolic and bariatric surgery on morbidly obese patients with type 2 DM. J Korean Surg Soc 2010;79:8-13.
20. Han SM, Kim WW. Early management of type 2 diabetes mellitus after sleeve gastrectomy in morbid obesity. J Korean Surg Soc 2005;69:304-9.
21. Cohen R, Pinheiro JS, Correa JL, Schiavon CA. Laparosco-pic Roux-en-Y gastric bypass for BMI < 35 kg/m(2): a tailored approach. Surg Obes Relat Dis 2006;2:401-4. (Pubitemid 43812096)
22. Kang HW, Kim DJ, Lee MS, Kim KW, Lee MK. Pathophys-iologic heterogeneity in the development of type 2 diabetes mellitus in Korean subjects. Diabetes Res Clin Pract 2005; 69:180-7.
23. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest 2006;116:1802-12. (Pubitemid 44033300)
24. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44: 968-83.
25. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
26. Kim DJ, Song KE, Park JW, Cho HK, Lee KW, Huh KB. Clinical characteristics of Korean type 2 diabetic patients in 2005. Diabetes Res Clin Pract 2007;77 Suppl 1:S252-7.
27. Dixon JB, Pories WJ, O'Brien PE, Schauer PR, Zimmet P. Surgery as an effective early intervention for diabesity: why the reluctance? Diabetes Care 2005;28:472-4. (Pubitemid 40170966)
28. Zervos EE, Agle SC, Warren AJ, Lang CG, Fitzgerald TL, Dar M, et al. Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes. J Am Coll Surg 2010;210:564-72, 572-4.
29. Lee WJ, Ser KH, Chong K, Lee YC, Chen SC, Tsou JJ, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery 2010;147:664-9.